Lv11
30 积分 2024-06-23 加入
Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials
1小时前
待确认
Association between dietary amino acid intake and the risk of metabolic dysfunction-associated steatotic liver disease
2个月前
已完结
Personalised therapy for Helicobacter pylori eradication: A non-inferiority, randomised trial comparing tailored versus empirical therapy
3个月前
已关闭
Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled,non-inferiority trials
4个月前
已完结
Advances in the Co-management of Metabolism Dysfunction-associated Fatty Liver Disease and Type 2 Diabetes Mellitus
4个月前
已完结
Antibiotic resistance of Helicobacter pylori in Mainland China: A focus on geographic differences through systematic review and meta-analysis
4个月前
已完结
454例幽门螺杆菌耐药性及药敏试验个性化诊疗效果分析
4个月前
已完结
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
4个月前
已完结
Associations of Alcohol Consumption and Genetic Predisposition to Hepatic Steatosis With Liver-Related Events: Results From Large Population-Based Cohort Studies
4个月前
已完结
Association of Healthy Lifestyle Behaviours With Incident Inflammatory Bowel Disease_ A Population-Based Prospective Cohort Stud(科研通-ablesci.com)
4个月前
已完结
皖公网安备34019202002308
